# The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.

> **NCT00280085** · NA · TERMINATED · sponsor: **Pfizer** · enrollment: 29 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **PROCEDURE:** MR imaging
- **PROCEDURE:** Glucose clamp
- **DRUG:** Arginine

## Key facts

- **NCT ID:** NCT00280085
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Explanation provided in detailed descriptiong section of record.
- **Last updated:** 2009-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00280085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00280085, "The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00280085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*